Alzheimer's disease (AD) is pathologically characterized by deposition of β-amyloid (Aβ) peptides, which closely correlates with the balance of nerve growth factor (NGF)-related TrkA/p75NTR signaling. This evidence concerns the gene NTRK1 and early-onset autosomal dominant Alzheimer disease.